Page last updated: 2024-10-16

quinacrine and Mouth Diseases

quinacrine has been researched along with Mouth Diseases in 5 studies

Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.

Mouth Diseases: Diseases involving the MOUTH.

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lerman, MA1
Karimbux, N1
Guze, KA1
Woo, SB1
Martin, TJ1
Sharp, I1
Sloan, P1
Kujan, O1
Kleinegger, CL1
Hammond, HL1
Finkelstein, MW1
Duperrat, B1
Puissant, A1
Pringuet, R1
Revuz, J1
Barrade, A1

Other Studies

5 other studies available for quinacrine and Mouth Diseases

ArticleYear
Pigmentation of the hard palate.
    Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2009, Volume: 107, Issue:1

    Topics: Antimalarials; Diagnosis, Differential; Female; Humans; Lupus Erythematosus, Discoid; Melanosis; Mid

2009
Oral mucosal pigmentation secondary to treatment with mepacrine, with sparing of the denture bearing area.
    The British journal of oral & maxillofacial surgery, 2004, Volume: 42, Issue:4

    Topics: Denture, Partial; Dermatologic Agents; Female; Humans; Lupus Erythematosus, Cutaneous; Melanosis; Mi

2004
Re: Martin TJM, Sharp I, Oral mucosal pigmentation secondary to treatment with mepacrine, with sparing of the denture bearing area (Br J Oral Maxillofac Surg 2004;42:351-3).
    The British journal of oral & maxillofacial surgery, 2005, Volume: 43, Issue:3

    Topics: Denture Bases; Denture, Partial; Dermatologic Agents; Humans; Iron; Male; Melanosis; Middle Aged; Mo

2005
Oral mucosal hyperpigmentation secondary to antimalarial drug therapy.
    Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2000, Volume: 90, Issue:2

    Topics: Adult; Antimalarials; Humans; Male; Melanosis; Mouth Diseases; Mouth Mucosa; Quinacrine

2000
[Predominantly buccopharyngeal, malignant pemphigus, cortico-resistant for a long time, responsive to a corticoid-aureomycin-quinacrine combination].
    Bulletin de la Societe francaise de dermatologie et de syphiligraphie, 1969, Volume: 76, Issue:1

    Topics: Adult; Chlortetracycline; Dexamethasone; Drug Synergism; Humans; Male; Mouth Diseases; Pemphigus; Ph

1969